IRIS
BONINI, MARIA CHIARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.167
NA - Nord America 1.686
AS - Asia 1.095
SA - Sud America 19
OC - Oceania 12
AF - Africa 6
Totale 4.985
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.666
SE - Svezia 1.099
SG - Singapore 518
IT - Italia 427
RU - Federazione Russa 367
CN - Cina 358
FI - Finlandia 83
HK - Hong Kong 74
DE - Germania 59
IE - Irlanda 55
JP - Giappone 51
IN - India 41
GB - Regno Unito 22
SA - Arabia Saudita 15
BR - Brasile 13
IL - Israele 13
FR - Francia 12
CA - Canada 11
IR - Iran 10
AT - Austria 8
CH - Svizzera 8
NL - Olanda 8
AU - Australia 6
DO - Repubblica Dominicana 6
NZ - Nuova Zelanda 6
ES - Italia 5
AR - Argentina 4
DK - Danimarca 4
TH - Thailandia 4
TW - Taiwan 4
MX - Messico 3
BE - Belgio 2
DZ - Algeria 2
EG - Egitto 2
KR - Corea 2
PE - Perù 2
PL - Polonia 2
EE - Estonia 1
IQ - Iraq 1
JO - Giordania 1
KG - Kirghizistan 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
MG - Madagascar 1
MK - Macedonia 1
PK - Pakistan 1
PT - Portogallo 1
UA - Ucraina 1
VN - Vietnam 1
Totale 4.985
Salva come PNG Salva come JPEG
Città #
Lawrence 409
Princeton 409
Singapore 339
Ashburn 195
Milan 178
Shanghai 146
Moscow 138
New York 137
Helsinki 72
Dublin 52
Boardman 46
Washington 28
Guangzhou 26
Rome 25
Beijing 21
Pune 21
Los Angeles 18
Dallas 16
Seattle 13
Lappeenranta 11
Tokyo 11
Borås 10
Jiaxing 10
Boston 8
Hanover 8
Shenzhen 8
Turin 8
Brescia 7
Rockville 7
Bologna 6
Naples 6
San Jose 6
Santa Clara 6
Shijiazhuang 6
São Paulo 6
Andover 5
Casale Monferrato 5
Cotui 5
Falls Church 5
Genoa 5
Jeddah 5
Monza 5
Overland Park 5
Philadelphia 5
Acton 4
Al Qatif 4
Bangkok 4
Cambridge 4
Hong Kong 4
Hyderabad 4
Moreno Valley 4
Mountain View 4
Mumbai 4
Redwood City 4
St Petersburg 4
Toronto 4
Vauderens 4
Wuxi 4
Xi'an 4
Zurich 4
Aci Sant'Antonio 3
Ballincollig 3
Busto Arsizio 3
Cantù 3
Chapel Hill 3
Chiyoda-ku 3
Cinisello Balsamo 3
Clifton 3
Copenhagen 3
Ferrara 3
Florence 3
Hadera 3
Ibaraki 3
Iowa City 3
Kfar Saba 3
London 3
Melbourne 3
Monrovia 3
Munich 3
Newark 3
Oberndorf bei Salzburg 3
Osimo 3
Paris 3
Pavia 3
Phoenix 3
Pisa 3
Pomona 3
Riyadh 3
Santo André 3
Segrate 3
St Louis 3
Tel Aviv 3
Vienna 3
Zhengzhou 3
Albairate 2
Albuquerque 2
Avellino 2
Barcelona 2
Baronissi 2
Birmingham 2
Totale 2.636
Salva come PNG Salva come JPEG
Nome #
CD4 CAR-T cells targeting CD19 play a key role in exacerbating cytokine release syndrome, while maintaining long-term responses 110
Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study 76
MODELING ADOPTIVE IMMUNOTHERAPY IN MOUSE-HUMANS CHIMERAS TO IDENTIFY NOVEL MECHANISMS OF LEUKEMIA IMMUNOEDITING 71
Clinical impact of suicide gene therapy in allogeneic hematopoietic stem cell transplantation 61
Case report: Ponatinib as a bridge to CAR-T cells and subsequent maintenance in a patient with relapsed/refractory Philadelphia-like acute lymphoblastic leukemia 51
Revealing and harnessing CD39 for the treatment of colorectal cancer and liver metastases by engineered T cells 50
Incidence, risk factors and clinical outcome of leukemia relapses with loss of the mismatched HLA after partially incompatible hematopoietic stem cell transplantation 43
Sirolimus-based graft-versus-host disease prophylaxis promotes the in vivo expansion of regulatory T cells and permits peripheral blood stem cell transplantation from haploidentical donors 42
A clinical protocol for gene transfer into peripheral blood lymphocytes for in vivo immunomodulation of donor anti-tumor immunity in patients affected by recurrent disease after allogeneic bone marrow transplantation 40
Loss of mismatched HLA in leukemia after stem-cell transplantation 39
Transfer of the HSV-tk gene into donor peripheral blood lymphocytes for in vivo modulation of donor anti-tumor immunity after allogeneic bone marrow transplantation 37
Dynamics of polyclonal immuno-reconstitution after allogeneic transplant with post-transplant cyclophosphamide and letermovir 35
A longitudinal analysis of humoral, T cellular response and influencing factors in a cohort of healthcare workers: Implications for personalized SARS-CoV-2 vaccination strategies 34
Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer 34
CRISPR-based gene disruption and integration of high-avidity, WT1-specific T cell receptors improve antitumor T cell function 33
Biobanking for COVID-19 research 30
Unconventional CD147-dependent platelet activation elicited by SARS-CoV-2 in COVID-19 29
Case Report: Favorable outcome of allogeneic hematopoietic stem cell transplantation in SARSCoV2 positive recipient, risk-benefit balance between infection and leukemia 28
Immunoediting of the genomic and transcriptional profile of acute myeloid leukaemia in response to allogeneic haematopoietic stem cell transplantation 28
Disrupting N-glycan expression on tumor cells boosts chimeric antigen receptor T cell efficacy against solid malignancies 28
Interleukin-7 improves the fitness of regulatory T cells for adoptive transfer 28
Adoptive T-cell therapy for cancer: The era of engineered T cells 27
Site-specific integration and tailoring of cassette design for sustainable gene transfer 27
Tracking genetically engineered lymphocytes long-term reveals the dynamics of T cell immunological memory 26
Immune Reconstitution-Based Score for Risk Stratification of Chronic Graft-Versus-Host Disease Patients 26
A Fas-based suicide switch in human T cells for the treatment of graft-versus-host disease 25
Abrogation of GvHD and early immune reconstitution after infusion of HSV-TK engineered donor lymphocytes after haplo-identical hemopoietic stem cell transplantation. 25
A humanized Fas receptor-based suicide switch expressed in human T lymphocytes for the induction of controlled graft versus leukemia. 25
Allogeneic hematopoietic stem cell transplantation for neuromyelitis optica. 25
FAS-based suicide gene strategy for controlled GvHD: An alternative to HSV-tk. 24
T cells for suicide gene therapy: Activation, functionality and clinical relevance 24
A new suicide system based on gene transfer of FAS into donor lymphocytes for controlled GVL. 24
A dual role for genetically modified lymphocytes in cancer immunotherapy 24
A CD8α− Subset of CD4+SLAMF7+ Cytotoxic T Cells Is Expanded in Patients With IgG4-Related Disease and Decreases Following Glucocorticoid Treatment 24
A novel immunopeptidomic-based pipeline for the generation of personalized oncolytic cancer vaccines 24
CRISPR/CAS9-BASED GENOME EDITING TO MODEL THE ANTI-LEUKEMIA IMMUNE RESPONSE AND IDENTIFY ITS MOLECULAR PLAYERS 23
Posttransplantation Cyclophosphamide- and Sirolimus-Based Graft-Versus-Host-Disease Prophylaxis in Allogeneic Stem Cell Transplant 23
Suicide gene transduced for the regulation of the graft-versus-leukemia effect 22
T Cell Suicide Gene Therapy Prompts Thymic Renewal in Adults After Haploidentical Hematopoietic Stem Cell Transplantation in the Absence of Post-Transplant Immunesuppression 22
Immune Effector Cell-Associated Hematotoxicity (ICAHT): EHA/EBMT Consensus Grading and Best Practice Recommendations 21
Adoptive immunotherapy with genetically modified lymphocytes in allogeneic stem cell transplantation 21
A novel self-lipid antigen targets human T cells against CD1c(+) leukemias 21
In-vivo T-regs generation by rapamycin-mycophenolate-ATG as a new platform for GvHD prophylaxis in T-cell repleted unmanipulated haploidentical peripheral stem cell transplantation: results in 59 patients 21
Editing Human Lymphocyte Specificity for Safe and Effective Adoptive Immunotherapy of Leukemia 21
Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation 21
CD4+ Memory Stem T Cells Recognizing Citrullinated Epitopes Are Expanded in Patients With Rheumatoid Arthritis and Sensitive to Tumor Necrosis Factor Blockade 21
CXCL10 levels at hospital admission predict COVID-19 outcome: hierarchical assessment of 53 putative inflammatory biomarkers in an observational study 21
Intra-arterial transplantation of HLA-matched donor mesoangioblasts in Duchenne muscular dystrophy 20
A T cell epitope encoded by a subset HLA-DPB1 alleles determines nonpermissive mismatches for hematologic stem cell transplantation 20
From TCR Gene Transfer to TCR Gene Editing of Central Memory T Lymphocytes for Immunotherapy of Leukemia 20
TCR gene editing results in effective immunotherapy of leukaemia without the development of GvHD 20
Flow cytometry data mining by cytoChain identifies determinants of exhaustion and stemness in TCR-engineered T cells 20
Expression of inducible factors reprograms CAR-T cells for enhanced function and safety 19
Infusion of HSV-tk genetically-engineered donor lymphocytes restores anti-viral immunity early after allogeneic BMT. 19
Targeted genome editing in human repopulating haematopoietic stem cells 19
Herpes simplex virus thymidine kinase gene transfer for controlled graft-versus-host disease and graft-versus-leukemia: Clinical follow-up and improved new vectors 19
A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCR 19
819. Molecular Follow-Up of Patients Treated with Allogeneic Hematopoietic Stem Cell Transplantation and Donor Lymphocytes Transduced with a Retroviral Vector Expressing HSV-TK and ∆LNGFR 19
Allogeneic haematopoietic stem cell transplantation in refractory neuromyelitis optica spectrum disorders 19
NK cell recovery after haploidentical HSCT with posttransplant cyclophosphamide: Dynamics and clinical implications 19
NY-ESO-1 TCR single edited stem and central memory T cells to treat multiple myeloma without graft-versus-host disease 19
A phase II multicenter trial of HSV-TK engineered donor lymphocytes after haplo-identical HSCT: Early immune reconstitution and abrogation of GvHD 19
Clinical and molecular features associated with acute myeloid leukemia engraftment in immunodeficient mouse models 19
Anti-SARS-CoV-2 T-stem cell memory persists in ocrelizumab-treated MS patients 18
CD4 CAR T Cells Drive Extensive CD8 CAR T Cell Expansion, Leading to Severe Cytokine Release Syndrome 18
Time to evolve: predicting engineered T cell-associated toxicity with next-generation models 18
Use of HSV-TK transduced donor lymphocytes in the context of allogeneic bone marrow transplantation: A paradigm of current applications and limitations in gene therapy 18
A pilot study of HSV-TK gene transfer into donor peripheral blood lymphocytes for controlled GVL after allo-BMT. 18
Safety and Efficacy of Donor T Cells Engineered with Herpes Simplex Virus Thymidine-Kinase Suicide Gene (TK Cells) Given after T-Cell Depleted (TCD) Haploidentical Hematopoietic Transplantation (Haplo-HSCT): Results of a 14-Year Follow-Up in 45 Patients 17
Cytomegalovirus-specific T cells restricted for shared and donor human leukocyte antigens differentially impact on Cytomegalovirus reactivation risk after allogeneichematopoietic stem cell transplantation 17
Improving the safety of cell therapy with the TK-suicide gene. 17
Alterations in the genomic and transcriptional profile of leukemia upon the immune pressure of allogenic hematopoietic stem cell transplantation: tracking immunoediting by high-throughput techniques 17
T Cell Receptor Gene Transfer into Early Differentiated Lymphocytes by Lentiviral Vectors for Safe and Effective Adoptive Immune Therapy of Leukemia 17
Editing Human Lymphocyte Specificity for Safe and Effective Adoptive Immunotherapy of Leukemia 17
Early molecular diagnosis of aspergillosis in a patient with acute myeloid leukaemia 17
Rapamycin-Based GvHD Prophylaxis Is Effective in T-Cell Replete Unmanipulated Haploidentical Peripheral Stem Cell Transplantation for Advanced Haematological Malignancies: Results in 46 Patients 17
Genomic typing for patient-specific human leukocyte antigen-alleles is an efficient tool for relapse detection of high-risk hematopoietic malignancies after stem cell transplantation from alternative donors 17
Immune monitoring in allogeneic hematopoietic stem cell transplant recipients: a survey from the EBMT-CTIWP 17
HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia 17
The potential immunogenicity of the TK suicide gene does not prevent full clinical benefit associated with the use of TK-transduced donor lymphocytes in HSCT for hematologic malignancies 17
Monitoring for virus-specific T-cell responses and viremia in allogeneic HSCT recipients: a survey from the EBMT Cellular Therapy & Immunobiology Working Party 16
Reinfusion of Hsv-TK engineered donor lymphocytes after haplo-identical hemopoietic stem cell transplantation provide early immune reconstitution without GvHD. 16
Suicide gene transduced T-cells for the regulation of the graft-versus-leukemia effect 16
A model system for functional evaluation of isolated MHC disparities 16
Editing Human Lymphocyte Specificity for Safe and Effective Adoptive Immunotherapy of Leukemia 16
In vivo tracking of T cells in humans unveils decade-long survival and activity of genetically modified T memory stem cells 16
T memory stem cells in health and disease 16
Acute Myeloid Leukemia Relapses after Allogenenic HSCT Display a Distinctive Immune-Related Signature, with Frequent and Functionally Relevant Alterations in HLA Class II Antigen Presentation and T Cell Costimulation 16
Allogeneic Hematopoietic Stem Cell Transplantation For Severe Neuromyelitis Optica 16
Enhancing anti-tumour efficacy with immunotherapy combinations 16
Graft-versus leukemia effect of HLA-haploidentical central-memory T cells expanded with leukemic APCs and modified with a suicide gene 16
Human T cells engineered with a leukemia lipid-specific TCR enables donor-unrestricted recognition of CD1c-expressing leukemia 16
Epithelial ovarian cancer is infiltrated by activated effector T cells co-expressing CD39, PD-1, TIM-3, CD137 and interacting with cancer cells and myeloid cells 15
Epigenetic checkpoints regulate the fate and function of CAR-T cells 15
CMV-specific T Cell Counts Early after Allogeneic Hematopoietic Stem Cell Transplantation Stratify the Risk of Subsequent CMV Reactivations: Results of a Prospective Observational Study 15
Long term follow-up in 30 patients receiving HSV-TK transduced donor lymphocytes after allo-BMT. 15
Genomic loss of mismatched HLA in leukemia is a major mechanism of in vivo escape from T cell immunosurveillance following haploidentical hematopoietic stem cell transplantation 15
Targeting Integration to Selected Genomic Loci and In Situ Tailoring of Cassette Design Allows Robust Transgene Expression without Perturbing Endogenous Transcription 15
Erratum: Tracking genetically engineered lymphocytes long-term reveals the dynamics of T cell immunological memory (Science Translational Medicine (2015) 7:319 (319er9)) 15
Human Herpesvirus 6 Infection Following Haploidentical Transplantation: Immune Recovery and Outcome 15
Totale 2.450
Salva come PNG Salva come JPEG
Categoria #
all - tutte 102.168
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 102.168
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20208 0 0 0 0 0 0 1 1 0 6 0 0
2020/202187 0 0 0 3 2 7 70 0 5 0 0 0
2021/2022278 0 0 0 125 25 7 18 34 13 23 7 26
2022/20232.256 918 480 124 22 55 256 84 124 96 28 50 19
2023/20241.308 51 58 140 129 118 240 156 99 21 53 62 181
2024/20251.235 728 106 99 183 119 0 0 0 0 0 0 0
Totale 5.272